Ramsey Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-26,000
Closed -$1.79M 22
2015
Q4
$1.79M Buy
26,000
+4,514
+21% +$298K 2.32% 20
2015
Q3
$1.27M Hold
21,486
2.24% 15
2015
Q2
$1.43M Hold
21,486
1.83% 20
2015
Q1
$1.39M Hold
21,486
1.83% 19
2014
Q4
$1.27M Hold
21,486
1.56% 22
2014
Q3
$1.1M Hold
21,486
1.43% 24
2014
Q2
$1.04M Hold
21,486
1.31% 29
2014
Q1
$1.12M Hold
21,486
1.5% 22
2013
Q4
$1.14M Hold
21,486
1.62% 18
2013
Q3
$994K Hold
21,486
1.53% 20
2013
Q2
$960K Buy
+21,486
New +$933K 1.45% 15

Other funds holding BMY

Ramsey Asset Management's BMY Position: Q1 2016 in Review

Ramsey Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2016, closing a stake of 26,000 shares — an estimated $1.79M sold.

Ramsey Asset Management first reported a position in BMY in Q2 2013 and held it in 11 quarters. The position peaked at $1.79M in Q4 2015. 1,523 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

  • Ramsey Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2016 after selling out during the quarter.
  • Ramsey Asset Management sold 26,000 Bristol-Myers Squibb shares in Q1 2016, an estimated $1.79M.
  • Ramsey Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 11 quarters.
  • Ramsey Asset Management's Bristol-Myers Squibb position peaked at $1.79M in Q4 2015.
  • 1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on Ramsey Asset Management's 13F filing for Q1 2016, filed 16 May 2016.